Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2010
11/18/2010WO2010111640A3 Anti-influenza formulations and methods
11/18/2010WO2010109434A3 A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it
11/18/2010WO2010106571A3 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
11/18/2010WO2010103365A3 Sustained release composition of therapeutic agent
11/18/2010WO2010089763A3 Poly(n-vinyl caprolactam-co-acrylamide) microparticles for controlled release applications
11/18/2010WO2010082789A3 Anticancer compositions comprising cedrol in nanoparticle form
11/18/2010WO2010078569A3 Porous nanoparticle supported lipid bilayer nanostructures
11/18/2010WO2010077422A3 Formulations of single domain antigen binding molecules
11/18/2010WO2010077045A3 Pharmaceutical composition of lyophilized formulation and preparation method of the same
11/18/2010WO2010052748A3 Dry granulation in a gas stream
11/18/2010WO2010017965A3 SOLID LIPID MICROCAPSULES CONTAINING hGH
11/18/2010WO2010014541A3 Compositions and methods for treatment of hypercholesterolemia
11/18/2010WO2010002033A3 Tablet
11/18/2010WO2009129943A8 Formulation with reduced hygroscopicity
11/18/2010US20100292669 Method and apparatus for in situ drug delivery during distraction osteogenesis
11/18/2010US20100292660 Dermal delivery device with ultrasonic weld
11/18/2010US20100292648 Device and method for delivering or withdrawing a substance through the skin
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292272 Supramolecular co-colloids produced using macrocyclic polyanionic systems
11/18/2010US20100292216 Methods and Compositions for the Treatment of Psychiatric Conditions
11/18/2010US20100292182 Cystitis treatment with high dose chondroitin sulfate
11/18/2010US20100292139 Topical drug delivery using phosphatidylcholine
11/18/2010US20100291287 Polymeric plate bendable without thermal energy and methods of manufacture
11/18/2010US20100291245 Soft, chewable and orally dissolvable and/or disintegrable products
11/18/2010US20100291225 Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same
11/18/2010US20100291224 Nanostructures, methods of preparing and uses thereof
11/18/2010US20100291223 Treatment for dermatological conditions
11/18/2010US20100291222 Antioxidant nanosphere comprising [1,2]-dithiolane moieties
11/18/2010US20100291221 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
11/18/2010US20100291220 Antibiotic formulation and method of treatment
11/18/2010US20100291219 Methods and compositions relating to progenitor cells
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291217 Pharmaceutical compositions
11/18/2010US20100291216 Pharmaceutical compositions
11/18/2010US20100291215 Drug delivery matrices to enhance wound healing
11/18/2010US20100291214 Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
11/18/2010US20100291213 Composite non-woven fibrous webs having continuous particulate phase and methods of making and using the same
11/18/2010US20100291212 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
11/18/2010US20100291211 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
11/18/2010US20100291209 Organic compounds
11/18/2010US20100291208 Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
11/18/2010US20100291207 Pharmaceutical formulation comprising ezetimibe
11/18/2010US20100291206 Oral dosage form
11/18/2010US20100291205 Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse
11/18/2010US20100291204 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use thereof
11/18/2010US20100291203 Opioid Agonist/Antagonist Combinations
11/18/2010US20100291202 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
11/18/2010US20100291201 Coated pharmaceutical capsule dosage form
11/18/2010US20100291200 Formulations for poorly soluble drugs
11/18/2010US20100291199 Compositions and Methods For The Treatment and Prevention of Disease
11/18/2010US20100291198 Compositions of phytosterols with enhanced bioavailability
11/18/2010US20100291197 hot melt-filled soft capsules
11/18/2010US20100291196 Method of treatment of autism spectrum disorder with liposomal reduced glutathione
11/18/2010US20100291195 Topical delivery of l-arginine to cause beneficial effects
11/18/2010US20100291194 Compositions and Methods for Inhibiting Expression of a Mutant Gene
11/18/2010US20100291193 Immunogenic compositions comprising progastrin and uses thereof
11/18/2010US20100291192 Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria
11/18/2010US20100291191 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/18/2010US20100291190 Topical Composition For Anti-Aging Skin Treatment Using Dual DNA Repair Mechanism and Method of Use
11/18/2010US20100291189 Method for producing a membrane protein
11/18/2010US20100291188 Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same
11/18/2010US20100291186 Transdermal Administration of Tamsulosin
11/18/2010US20100291185 Theritol phosphates, salts thereof and methods of use
11/18/2010US20100291184 Wound dressing with apertured cover sheet
11/18/2010US20100291183 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
11/18/2010US20100291181 Therapeutic devices for patterned cell growth
11/18/2010US20100291179 Composite biomaterial for controlled release of active ingredients
11/18/2010US20100291177 Prevention of staphylococcus biofilm formation
11/18/2010US20100291174 Biologically active device and method for its production
11/18/2010US20100291173 Method of improving renal function
11/18/2010US20100291171 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking
11/18/2010US20100291170 Novel therapies for chronic renal failure
11/18/2010US20100291169 Polyelectrolyte Complex for Imparting Antimicrobial Properties to a Substrate
11/18/2010US20100291168 Antimicrobial formulations comprising a combination of a pyridine thiol and a bis-quinolinium salt
11/18/2010US20100291164 Functionalized calcium phosphate hybrid systems for the remineralization of teeth and a method for producing the same
11/18/2010US20100291162 Oral compositions providing enhanced tooth stain removal
11/18/2010US20100291161 Cellulose powder
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291159 Film coatings containing fine particle size detackifiers and substrates coated therewith
11/18/2010US20100291158 Sustained release oral composition of an antipsychotic agent
11/18/2010US20100291157 Composition for headache treatment
11/18/2010US20100291115 Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof
11/18/2010US20100291005 Use of trans-pellitorin as flavor substance
11/18/2010US20100291004 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
11/18/2010US20100291003 Histone deacetylase inhibitors
11/18/2010US20100291002 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/18/2010US20100290984 Anti-mrp3 antibodies and methods of use
11/18/2010DE102009020888A1 Schmelztablette, enthaltend ein Vardenafil-Salz Melting tablet containing a vardenafil salt
11/18/2010CA2763368A1 Pharmaceutical system for trans-membrane delivery
11/18/2010CA2762107A1 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010CA2761947A1 Coated pharmaceutical capsule dosage form
11/18/2010CA2761937A1 Hyaluronic acid (ha) injection vehicle
11/18/2010CA2761917A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
11/18/2010CA2761916A1 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010CA2761801A1 Compositions and methods for drug delivery
11/18/2010CA2761795A1 Burst drug release compositions
11/18/2010CA2761740A1 Phosphate-free pharmaceutical composition for the treatment of glaucoma
11/18/2010CA2761739A1 Oil-in-water emulsion of mometasone and propylene glycol
11/18/2010CA2761678A1 Method and composition to improve absorption of therapeutic agents
1 ... 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 ... 2991